A study of an effective sunitinib–chemotherapeutic combination regimen for bladder cancer treatment using a mouse model
Objective: To determine if tyrosine kinase receptor inhibitor, sunitinib malate, combined with chemotherapeutic drugs may present synergistic enhancement of cytotoxicity to transitional cell carcinoma cells (TCC). Methods: The mRNA and protein contents of vascular endothelial growth factor-α (VEGFα)...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2014-06-01
|
| Series: | Urological Science |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1879522613001292 |